AAminove
Back to library

Selank

Human observational
CognitiveAnxiolytic / cognition (claimed)

Community-reported ranges are anecdotal and not clinically validated. Evidence grade shown reflects the strength of available human data. Not a prescription. Legal status varies by country and changes over time; verify locally.

Overview

An anxiolytic peptide developed in Russia. Like Semax, it has regional clinical history but limited independent evidence.

Mechanism

Proposed to modulate GABA/serotonin systems and tuftsin-like immunomodulation; human mechanism uncertain.

Evidence

Human observationalWhat does this mean?

Some regional clinical use; independent RCT evidence limited.

Community-reported information

Community reports vary. Anecdotal and unvalidated; general information only.

General information only, not tailored to you and not a recommendation. Some regions withhold this entirely.

Half-life

Short (intranasal use common).

Storage

Refrigerate solutions.

Commonly reported side effects

  • Not well characterised
  • Nasal irritation (intranasal)

Legal status by region

  • USNot FDA-approved; not a lawful supplement ingredient.

Legal status changes over time; verify locally before relying on this.

Citations